Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin ; volume:12 ; number:2 ; day:7 ; month:4 ; year:2010 ; pages:1-10 ; date:4.2010
Arthritis Research & Therapy ; 12, Heft 2 (7.4.2010), 1-10, 4.2010
- Creator
-
Usui, Chie
- Contributor
-
Hatta, Kotaro
Doi, Nagafumi
Nakanishi, Atsushi
Nakamura, Hiroyuki
Nishioka, Kusuki
Arai, Heii
SpringerLink (Online service)
- DOI
-
10.1186/ar2980
- URN
-
urn:nbn:de:1111-2016050315299
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Usui, Chie
- Hatta, Kotaro
- Doi, Nagafumi
- Nakanishi, Atsushi
- Nakamura, Hiroyuki
- Nishioka, Kusuki
- Arai, Heii
- SpringerLink (Online service)
Other Objects (12)
Predicting IVF outcome in poor ovarian responders
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Corifollitropin alfa for poor responders patients, a prospective randomized study
Individualized controlled ovarian stimulation in expected poor-responders: an update
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Cardiovascular and cardiorespiratory effects of high-intensity interval training in body fat responders and non-responders
Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Electroconvulsive therapy for adolescents with severe depressive episode and suicidality: retrospective comparison between responders and non-responders
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
Effects of mandibular advancement devices on upper airway dimensions in obstructive sleep apnea: responders versus non-responders
Predicting IVF outcome in poor ovarian responders
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Corifollitropin alfa for poor responders patients, a prospective randomized study
Individualized controlled ovarian stimulation in expected poor-responders: an update
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Cardiovascular and cardiorespiratory effects of high-intensity interval training in body fat responders and non-responders
Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Electroconvulsive therapy for adolescents with severe depressive episode and suicidality: retrospective comparison between responders and non-responders
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
Effects of mandibular advancement devices on upper airway dimensions in obstructive sleep apnea: responders versus non-responders
Predicting IVF outcome in poor ovarian responders
Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
Corifollitropin alfa for poor responders patients, a prospective randomized study
Individualized controlled ovarian stimulation in expected poor-responders: an update
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Cardiovascular and cardiorespiratory effects of high-intensity interval training in body fat responders and non-responders
Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
Electroconvulsive therapy for adolescents with severe depressive episode and suicidality: retrospective comparison between responders and non-responders
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience